Danaher Corporation (DHR : NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends
Company Report I 2024-11-22 I 108 Pages I Quaintel Research
Report Summary
Year End Offer - Buy Now and get an updated version of this Report at no extra cost within 30 days of the release of Company's next Annual Report. (Offer expires on 31st Dec 2024)
Danaher Corporation (DHR : NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends Report is a comprehensive and easily accessible overview of Danaher Corporation's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Danaher Corporation including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Danaher Corporation's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Danaher Corporation's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Danaher Corporation's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Danaher Corporation's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Danaher Corporation enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Danaher Corporation is a globally recognized science and technology innovator that drives advancements in the life sciences, diagnostics, and biotechnology industries. Founded in 1984, Danaher has evolved through strategic acquisitions and divestitures, establishing leadership positions in each of its primary segments. The company operates through a diverse range of subsidiaries, offering products and services that aid in critical areas such as drug discovery, clinical diagnostics, and biotechnology manufacturing.
Danaher's strategic approach includes the use of its proprietary Danaher Business System (DBS), which focuses on continuous improvement across all operational areas, from product development to customer engagement. This system enables Danaher to consistently deliver innovative, high-quality products tailored to meet the stringent requirements of the healthcare and research sectors.
Danaher's portfolio includes notable brands such as Beckman Coulter, Cepheid, Cytiva, and Molecular Devices, which collectively provide tools, consumables, software, and services for laboratories, healthcare facilities, and biopharmaceutical companies. The company also emphasizes sustainable practices, aiming to reduce its environmental footprint while developing solutions that enhance global healthcare outcomes.
Danaher Corporation in the News:-
- 22-Oct-2024 - Danaher Reports Third Quarter 2024 Results
- 19-Sep-2024 - Danaher Schedules Third Quarter 2024 Earnings Conference Call
- 10-Sep-2024 - Danaher Announces Quarterly Dividend
- 04-Sep-2024 - Danaher Confirms Third Quarter and Full Year 2024 Guidance
- 26-Aug-2024 - Danaher to Webcast Diagnostics Investor and Analyst Meeting in Washington, D.C.
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Danaher Corporation's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Danaher Corporation:
- Danaher Corporation Value Chain Analysis
- Danaher Corporation Porter's Five Forces Analysis
- Danaher Corporation VRIO Analysis
- Danaher Corporation BCG Analysis
- Danaher Corporation Segmentation, Targeting and Positioning (STP) Analysis
- Danaher Corporation Ansoff Matrix Analysis
Table of Contents
COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 6
Charts 7
Danaher Corporation - Key Company Facts 8
Danaher Corporation - Company Description 9
Danaher Corporation - Top Executives 10
Danaher Corporation- Top Executives Biographies 11
Danaher Corporation- Head Office & Locations 13
Head Office - Country 13
Key Subsidiaries 14
Key Joint Ventures 16
Danaher Corporation - Products and Services 17
Products 17
Services 18
Danaher Corporation - Historic Events 19
Danaher Corporation - Company's Management Discussion 21
Danaher Corporation - Company's Mission and Vision 29
Vision 29
Danaher Corporation - Corporate Strategy 30
Danaher Corporation - Business Description 33
Biotechnology 33
Life Sciences 34
Diagnostics 34
Danaher Corporation - ESG Spotlight 36
Environment 36
Social 37
Corporate Governance 37
Danaher Corporation - SWOT Analysis 39
Overview 39
Strengths 41
Weaknesses 44
Opportunities 46
Threats 47
Danaher Corporation - PESTLE Analysis 49
Overview 49
Political Factors 51
Economic Factors 52
Social Factors 54
Technological Factors 56
Legal Factors 57
Environmental Factors 59
Danaher Corporation - Financial Deep Dive 60
Share Price Trend - Nov-2023 to Nov-2024 (Average Share Closing Price) 60
Profit and Loss Statement 62
Summary of Profit and Loss Statement 62
Balance Sheet 64
Summary of Balance Sheet 64
Cash Flow Statement 66
Summary of Cash Flow Statement 66
Key Financial Ratio Analysis 68
Danaher Corporation - Ratio Charts 69
Activity Ratio Charts 69
Growth Ratios Charts 70
Leverage Ratio Charts 71
Liquidity Ratio Charts 72
Profitability Ratio Charts 73
Competing Players 74
Snapshot of Competing Players 75
Abbott Laboratories 75
Key Company Facts 75
Company Description 75
Becton, Dickinson and Company 76
Key Company Facts 76
Company Description 76
Boston Scientific Corporation 77
Key Company Facts 77
Company Description 77
Illumina Inc. 78
Key Company Facts 78
Company Description 78
Siemens Healthineers AG 79
Key Company Facts 79
Company Description 79
Thermo Fisher Scientific Inc. 80
Key Company Facts 80
Company Description 80
Danaher Corporation - In the News 81
22-Oct-2024 - Danaher Reports Third Quarter 2024 Results 81
19-Sep-2024 - Danaher Schedules Third Quarter 2024 Earnings Conference Call 83
10-Sep-2024 - Danaher Announces Quarterly Dividend 84
04-Sep-2024 - Danaher Confirms Third Quarter and Full Year 2024 Guidance 84
26-Aug-2024 - Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C. 84
23-Jul-2024 - Danaher Reports Second Quarter 2024 Results 85
17-Jul-2024 - Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development 87
16-Jul-2024 - Danaher Releases 2024 Sustainability Report 89
19-Jun-2024 - Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics 91
05-Jun-2024 - Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer 92
23-Apr-2024 - Danaher Reports First Quarter 2024 Results 92
03-May-2023 - Danaher to present at bank of america securities health care conference 93
07-Mar-2023 - Danaher partners with the university of pennsylvania's center for cellular immunotherapies to address manufacturing challenges impacting the uptake of cell therapies 94
08-Feb-2023 - Danaher announces new environmental and applied solutions company to be named veralto 95
10-Nov-2022 - Danaher launches beacon initiative and its first partnership focused on gene therapy innovation 96
14-Sep-2022 - Danaher announces intention to separate environmental & applied solutions segment to create an independent, publicly traded company 97
Danaher Corporation - Key Deals 98
11-Jul-2024 - Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening 98
06-Dec-2023 - Danaher Completes Acquisition of Abcam 99
31-Aug-2021 - Danaher Completes Acquisition of Aldevron 99
Appendix 100
Definitions 100
SWOT Analysis 100
PESTLE Analysis 100
Value Chain Analysis 100
ESG Spotlight 100
Financial Deep Dive 100
Financial Ratios - 101
Activity Ratios 101
Growth Ratios 102
Leverage Ratios 103
Liquidity Ratios 104
Market Ratios 105
Profitability Ratios 105
Research Methodology 106
Disclaimer 107
Contact Us 107
Tables
Table 1: Danaher Corporation - Company Facts 8
Table 2: Danaher Corporation - Digital Presence 8
Table 3: Danaher Corporation - Top Executives 10
Table 4: Danaher Corporation - Top Executives Biographies 11
Table 5: Danaher Corporation - Subsidiaries 14
Table 6: Danaher Corporation - Key Joint Ventures 16
Table 7: Danaher Corporation - Products 17
Table 8: Danaher Corporation - Services 18
Table 9: Danaher Corporation - Historic Events 19
Table 10: Danaher Corporation - Share Price Trend - Nov-2023 to Nov-2024 60
Table 11: Danaher Corporation - Ratio Analysis - 2020-2023 68
Table 12: Danaher Corporation - Competing Players 74
Table 13: Competing Players - Abbott Laboratories - Key Company Facts 75
Table 14: Competing Players - Becton, Dickinson and Company - Key Company Facts 76
Table 15: Competing Players - Boston Scientific Corporation - Key Company Facts 77
Table 16: Competing Players - Illumina Inc. - Key Company Facts 78
Table 17: Competing Players - Siemens Healthineers AG - Key Company Facts 79
Table 18: Competing Players - Thermo Fisher Scientific Inc. - Key Company Facts 80
Charts
Figure 1: Danaher Corporation- SWOT Analysis 40
Figure 2: Danaher Corporation - PESTLE Analysis 50
Figure 3: Danaher Corporation - Average Share Price Trend - Nov-2023 to Nov-2024 61
Figure 4: Danaher Corporation - Profit and Loss Statement - 2020-2023 63
Figure 5: Danaher Corporation - Balance Sheet - 2020-2023 65
Figure 6: Danaher Corporation - Cash Flow Statement 2020-2023 67
Figure 7: Danaher Corporation - Activity Ratio Charts 69
Figure 8: Danaher Corporation - Growth Ratio Charts (Value %) 70
Figure 9: Danaher Corporation - Leverage Ratio Charts 71
Figure 10: Danaher Corporation - Liquidity Ratio Charts 72
Figure 11: Danaher Corporation - Profitability Ratio Charts (Value %) 73
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.